APO RESEARCH · REPORT
Post herpetic Neuralgia Treatment
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Product & engineering
Understand the product.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Selected research
Industry Research
Post herpetic Neuralgia Treatment Industry Research Report 2026
Market perspective
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
Read the full market overview
In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
Report Scope
This report quantifies the global Post herpetic Neuralgia Treatment market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Post herpetic Neuralgia Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Post herpetic Neuralgia Treatment Market by Company
Pfizer
Arbor Pharma
Assertio Therapeutics
Endo Pharma
Teikoku Pharma
Teva
Mylan
Hengrui Medicine
Post herpetic Neuralgia Treatment Segment by Type
Anticonvulsants
Skin Patch
Other
Post herpetic Neuralgia Treatment Segment by Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Post herpetic Neuralgia Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post herpetic Neuralgia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Post herpetic Neuralgia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post herpetic Neuralgia Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Post herpetic Neuralgia Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anticonvulsants
- Skin Patch
- Other
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Pfizer
- Arbor Pharma
- Assertio Therapeutics
- Endo Pharma
- Teikoku Pharma
- Teva
- Mylan
- Hengrui Medicine
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Post herpetic Neuralgia Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Anticonvulsants
- 2.2.3 Skin Patch
- 2.2.4 Other
- 2.3 Post herpetic Neuralgia Treatment by Distribution Channel
- 2.3.1 Market Value Comparison by Distribution Channel (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.4 Assumptions and Limitations
3 Post herpetic Neuralgia Treatment Breakdown Data by Type
- 3.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Type (2027-2032)
4 Post herpetic Neuralgia Treatment Breakdown Data by Distribution Channel
- 4.1 Global Post herpetic Neuralgia Treatment Historic Market Size by Distribution Channel (2021-2026)
- 4.2 Global Post herpetic Neuralgia Treatment Forecasted Market Size by Distribution Channel (2027-2032)
5 Global Growth Trends
- 5.1 Global Post herpetic Neuralgia Treatment Market Perspective (2021-2032)
- 5.2 Global Post herpetic Neuralgia Treatment Growth Trends by Region
- 5.2.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Post herpetic Neuralgia Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Post herpetic Neuralgia Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Post herpetic Neuralgia Treatment Market Dynamics
- 5.3.1 Post herpetic Neuralgia Treatment Industry Trends
- 5.3.2 Post herpetic Neuralgia Treatment Market Drivers
- 5.3.3 Post herpetic Neuralgia Treatment Market Challenges
- 5.3.4 Post herpetic Neuralgia Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue
- 6.1.1 Global Top Post herpetic Neuralgia Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Post herpetic Neuralgia Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Post herpetic Neuralgia Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Post herpetic Neuralgia Treatment Head Office and Area Served
- 6.4 Global Post herpetic Neuralgia Treatment Players, Product Type & Application
- 6.5 Global Post herpetic Neuralgia Treatment Manufacturers Established Date
- 6.6 Global Post herpetic Neuralgia Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Post herpetic Neuralgia Treatment Market Size (2021-2032)
- 7.2 North America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
- 7.4 North America Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Post herpetic Neuralgia Treatment Market Size (2021-2032)
- 8.2 Europe Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
- 8.4 Europe Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Post herpetic Neuralgia Treatment Market Size (2021-2032)
- 10.2 South America Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
- 10.4 South America Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Pfizer
- 12.1.1 Pfizer Company Information
- 12.1.2 Pfizer Business Overview
- 12.1.3 Pfizer Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.1.4 Pfizer Post herpetic Neuralgia Treatment Product Portfolio
- 12.1.5 Pfizer Recent Developments
- 12.2 Arbor Pharma
- 12.2.1 Arbor Pharma Company Information
- 12.2.2 Arbor Pharma Business Overview
- 12.2.3 Arbor Pharma Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio
- 12.2.5 Arbor Pharma Recent Developments
- 12.3 Assertio Therapeutics
- 12.3.1 Assertio Therapeutics Company Information
- 12.3.2 Assertio Therapeutics Business Overview
- 12.3.3 Assertio Therapeutics Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio
- 12.3.5 Assertio Therapeutics Recent Developments
- 12.4 Endo Pharma
- 12.4.1 Endo Pharma Company Information
- 12.4.2 Endo Pharma Business Overview
- 12.4.3 Endo Pharma Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.4.4 Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio
- 12.4.5 Endo Pharma Recent Developments
- 12.5 Teikoku Pharma
- 12.5.1 Teikoku Pharma Company Information
- 12.5.2 Teikoku Pharma Business Overview
- 12.5.3 Teikoku Pharma Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio
- 12.5.5 Teikoku Pharma Recent Developments
- 12.6 Teva
- 12.6.1 Teva Company Information
- 12.6.2 Teva Business Overview
- 12.6.3 Teva Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.6.4 Teva Post herpetic Neuralgia Treatment Product Portfolio
- 12.6.5 Teva Recent Developments
- 12.7 Mylan
- 12.7.1 Mylan Company Information
- 12.7.2 Mylan Business Overview
- 12.7.3 Mylan Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.7.4 Mylan Post herpetic Neuralgia Treatment Product Portfolio
- 12.7.5 Mylan Recent Developments
- 12.8 Hengrui Medicine
- 12.8.1 Hengrui Medicine Company Information
- 12.8.2 Hengrui Medicine Business Overview
- 12.8.3 Hengrui Medicine Revenue in Post herpetic Neuralgia Treatment Business (2021-2026)
- 12.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio
- 12.8.5 Hengrui Medicine Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst